Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 and certain immune cells are linked to more severe alopecia areata.

CIP/KIP proteins help stop cell division and support hair growth.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Hair follicle dermal stem cells help control hair growth timing by regulating signals at the hair germ–dermal papilla interface.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

The mutant HR bmh protein mis-localizes in cells, affecting skin and hair development.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

HIV patients in Korea often have skin diseases like fungal infections, folliculitis, and seborrheic dermatitis, which are less common with effective HIV treatment.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Vinblastine can help treat childhood ITP but may cause reversible side effects.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

BCG injection helps reduce long COVID symptoms and affects hair loss differently in men and women.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

A rare genetic variant linked to skin cysts was found in blood DNA, suggesting its role in cyst formation.

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.